Clinical Trial Update: Iodine I 131 in Treating Patients With Thyroid Cancer [NA]

View source ↗

Summary

The Johns Hopkins-sponsored trial evaluating radioactive iodine I-131 for thyroid cancer was terminated, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Thyroid Cancer

Drugs mentioned

• Iodine-131 (Iodine-131)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Head and Neck Cancer | NA | Status: TERMINATED | Results posted: 2018-07-18